A single intranasal administration of AdCOVID protects against SARS-CoV-2 infection in the upper and lower respiratory tracts

The coronavirus disease 2019 (COVID-19) pandemic has illustrated the critical need for effective prophylactic vaccination to prevent the spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Intranasal vaccination is an attractive approach for preventing COVID-19 as the nasal mucos...

Descripción completa

Detalles Bibliográficos

Autores principales:	Michael D. Schultz, John J. Suschak, Davide Botta, Aaron Silva-Sanchez, R. Glenn King, Thomas W. Detchemendy, Chetan D. Meshram, Jeremy B. Foote, Fen Zhou, Jennifer L. Tipper, Jianfeng Zhang, Kevin S. Harrod, Sixto M. Leal, Troy D. Randall, M. Scot Roberts, Bertrand Georges, Frances E. Lund
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	Taylor & Francis Group 2022-11-01
Colección:	Human Vaccines & Immunotherapeutics
Materias:	covid-19 sars-cov-2 receptor binding domain vaccine adenovirus vector viral vector intranasal mucosal immunity
Acceso en línea:	http://dx.doi.org/10.1080/21645515.2022.2127292
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!